These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
424 related items for PubMed ID: 19786550
1. Long-lived colitogenic CD4+ memory T cells residing outside the intestine participate in the perpetuation of chronic colitis. Nemoto Y, Kanai T, Kameyama K, Shinohara T, Sakamoto N, Totsuka T, Okamoto R, Tsuchiya K, Nakamura T, Sudo T, Matsumoto S, Watanabe M. J Immunol; 2009 Oct 15; 183(8):5059-68. PubMed ID: 19786550 [Abstract] [Full Text] [Related]
2. Bone marrow retaining colitogenic CD4+ T cells may be a pathogenic reservoir for chronic colitis. Nemoto Y, Kanai T, Makita S, Okamoto R, Totsuka T, Takeda K, Watanabe M. Gastroenterology; 2007 Jan 15; 132(1):176-89. PubMed ID: 17241870 [Abstract] [Full Text] [Related]
3. Immunosenescent colitogenic CD4(+) T cells convert to regulatory cells and suppress colitis. Totsuka T, Kanai T, Nemoto Y, Tomita T, Tsuchiya K, Sakamoto N, Okamoto R, Watanabe M. Eur J Immunol; 2008 May 15; 38(5):1275-86. PubMed ID: 18412161 [Abstract] [Full Text] [Related]
4. Upregulated IL-7 receptor α expression on colitogenic memory CD4+ T cells may participate in the development and persistence of chronic colitis. Shinohara T, Nemoto Y, Kanai T, Kameyama K, Okamoto R, Tsuchiya K, Nakamura T, Totsuka T, Ikuta K, Watanabe M. J Immunol; 2011 Feb 15; 186(4):2623-32. PubMed ID: 21217010 [Abstract] [Full Text] [Related]
5. Continuous generation of colitogenic CD4(+) T cells in persistent colitis. Tomita T, Kanai T, Fujii T, Nemoto Y, Okamoto R, Tsuchiya K, Totsuka T, Sakamoto N, Watanabe M. Eur J Immunol; 2008 May 15; 38(5):1264-74. PubMed ID: 18412157 [Abstract] [Full Text] [Related]
6. Colitis-inducing potency of CD4+ T cells in immunodeficient, adoptive hosts depends on their state of activation, IL-12 responsiveness, and CD45RB surface phenotype. Claesson MH, Bregenholt S, Bonhagen K, Thoma S, Möller P, Grusby MJ, Leithäuser F, Nissen MH, Reimann J. J Immunol; 1999 Mar 15; 162(6):3702-10. PubMed ID: 10092833 [Abstract] [Full Text] [Related]
7. IL-2 is positively involved in the development of colitogenic CD4+ IL-7R alpha high memory T cells in chronic colitis. Kameyama K, Nemoto Y, Kanai T, Shinohara T, Okamoto R, Tsuchiya K, Nakamura T, Sakamoto N, Totsuka T, Hibi T, Watanabe M. Eur J Immunol; 2010 Sep 15; 40(9):2423-36. PubMed ID: 20623548 [Abstract] [Full Text] [Related]
8. IL-7 is essential for lymphopenia-driven turnover of colitogenic CD4(+) memory T cells in chronic colitis. Tomita T, Kanai T, Totsuka T, Nemoto Y, Okamoto R, Tsuchiya K, Sakamoto N, Ohteki T, Hibi T, Watanabe M. Eur J Immunol; 2009 Oct 15; 39(10):2737-47. PubMed ID: 19637223 [Abstract] [Full Text] [Related]
9. IL-7 promotes long-term in vitro survival of unique long-lived memory subset generated from mucosal effector memory CD4+ T cells in chronic colitis mice. Takahara M, Nemoto Y, Oshima S, Matsuzawa Y, Kanai T, Okamoto R, Tsuchiya K, Nakamura T, Yamamoto K, Watanabe M. Immunol Lett; 2013 Oct 15; 156(1-2):82-93. PubMed ID: 24070768 [Abstract] [Full Text] [Related]
10. Naturally arising CD4+CD25+ regulatory T cells suppress the expansion of colitogenic CD4+CD44highCD62L- effector memory T cells. Kanai T, Tanimoto K, Nemoto Y, Fujii R, Makita S, Totsuka T, Watanabe M. Am J Physiol Gastrointest Liver Physiol; 2006 May 15; 290(5):G1051-8. PubMed ID: 16373426 [Abstract] [Full Text] [Related]
11. Influence of intestinal bacteria on induction of regulatory T cells: lessons from a transfer model of colitis. Strauch UG, Obermeier F, Grunwald N, Gürster S, Dunger N, Schultz M, Griese DP, Mähler M, Schölmerich J, Rath HC. Gut; 2005 Nov 15; 54(11):1546-52. PubMed ID: 15987795 [Abstract] [Full Text] [Related]
12. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice. Elson CO, Cong Y, Weaver CT, Schoeb TR, McClanahan TK, Fick RB, Kastelein RA. Gastroenterology; 2007 Jun 15; 132(7):2359-70. PubMed ID: 17570211 [Abstract] [Full Text] [Related]
13. Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease. Kanai T, Nemoto Y, Kamada N, Totsuka T, Hisamatsu T, Watanabe M, Hibi T. Curr Opin Gastroenterol; 2009 Jul 15; 25(4):306-13. PubMed ID: 19448533 [Abstract] [Full Text] [Related]
14. IL-7 exacerbates chronic colitis with expansion of memory IL-7Rhigh CD4+ mucosal T cells in mice. Okada E, Yamazaki M, Tanabe M, Takeuchi T, Nanno M, Oshima S, Okamoto R, Tsuchiya K, Nakamura T, Kanai T, Hibi T, Watanabe M. Am J Physiol Gastrointest Liver Physiol; 2005 Apr 15; 288(4):G745-54. PubMed ID: 15550560 [Abstract] [Full Text] [Related]
15. Competition between colitogenic Th1 and Th17 cells contributes to the amelioration of colitis. Mikami Y, Kanai T, Sujino T, Ono Y, Hayashi A, Okazawa A, Kamada N, Matsuoka K, Hisamatsu T, Okamoto S, Takaishi H, Inoue N, Ogata H, Hibi T. Eur J Immunol; 2010 Sep 15; 40(9):2409-22. PubMed ID: 20706984 [Abstract] [Full Text] [Related]
18. Analysis of intestinal lymphocytes in mouse colitis mediated by transfer of CD4+, CD45RBhigh T cells to SCID recipients. Aranda R, Sydora BC, McAllister PL, Binder SW, Yang HY, Targan SR, Kronenberg M. J Immunol; 1997 Apr 01; 158(7):3464-73. PubMed ID: 9120308 [Abstract] [Full Text] [Related]
19. CpG motifs of bacterial DNA exert protective effects in mouse models of IBD by antigen-independent tolerance induction. Bleich A, Janus LM, Smoczek A, Westendorf AM, Strauch U, Mähler M, Hedrich HJ, Fichtner-Feigl S, Schölmerich J, Falk W, Hofmann C, Obermeier F. Gastroenterology; 2009 Jan 01; 136(1):278-87. PubMed ID: 18952084 [Abstract] [Full Text] [Related]
20. Lack of TNFR2 expression by CD4(+) T cells exacerbates experimental colitis. Dayer Schneider J, Seibold I, Saxer-Sekulic N, Paredes BE, Saurer L, Mueller C. Eur J Immunol; 2009 Jul 01; 39(7):1743-53. PubMed ID: 19551899 [Abstract] [Full Text] [Related] Page: [Next] [New Search]